These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4924915)

  • 1. [Results of treatment with rifampicin-isoniazid in 100 tubercular patients with sensitive bacilli a 6 to 24 month controlled experiment].
    Coury C; Constans P; Parrot R; Baron A
    Rev Tuberc Pneumol (Paris); 1970; 34(5):688-97. PubMed ID: 4924915
    [No Abstract]   [Full Text] [Related]  

  • 2. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampin and isoniazid in previously untreated patients with pulmonary tuberculosis.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Am Rev Respir Dis; 1972 Jan; 105(1):132-4. PubMed ID: 5007611
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
    Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
    Br J Dis Chest; 1972 Oct; 66(4):268-71. PubMed ID: 5083434
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months.
    Am Rev Respir Dis; 1977 Nov; 116(5):807-20. PubMed ID: 411405
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1979 Apr; 119(4):579-85. PubMed ID: 375787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-pharmacological approach to rifampicin and isoniazid dosage].
    Karkishchenko NN; Khoron'ko VV; Vorob'ev VS; Anisimova NB; Chubarian VT
    Probl Tuberk; 1987; (9):31-4. PubMed ID: 3422964
    [No Abstract]   [Full Text] [Related]  

  • 12. Consider rifampin BUT be cautious.
    Ashkin D; Julien J; Lauzardo M; Hollender E
    Chest; 2006 Dec; 130(6):1638-40. PubMed ID: 17166975
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month isoniazid-rifampin treatment for pulmonary tuberculosis in children.
    Reis FJ; Bedran MB; Moura JA; Assis I; Rodrigues ME
    Am Rev Respir Dis; 1990 Nov; 142(5):996-9. PubMed ID: 2240853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course chemotherapy for tuberculosis in children.
    Abernathy RS; Dutt AK; Stead WW; Moers DJ
    Pediatrics; 1983 Dec; 72(6):801-6. PubMed ID: 6606156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The short course therapies by Ryoken's method. 9 month and 12 month regimens including rifampicin (RFP) plus isoniazid (INH) in bacteriologically proved pulmonary tuberculosis].
    Gomi J; Aoyagi T; Fukuhara Y; Yamaguchi T; Matsumiya T
    Kekkaku; 1985 Aug; 60(8):435-45. PubMed ID: 3906218
    [No Abstract]   [Full Text] [Related]  

  • 17. A Singapore study of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis (1).
    Lee SK
    Bull Int Union Tuberc; 1976; 51(1):109-13. PubMed ID: 1030269
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preliminary results of a therapeutic trial concerning the administration of isoniazid + rifampicin once a week, immediately or after an initial period of continuous treatment].
    Eule H
    Bull Int Union Tuberc; 1973 Jun; 48(0):117-24. PubMed ID: 4602466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.